folic acid has been researched along with Carcinoma, Transitional Cell in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aben, KK; Ardanaz, E; Boeing, H; Boutron-Ruault, MC; Brennan, P; Büchner, FL; Bueno-De-Mesquita, HB; Cadeau, C; Chang-Claude, J; Chirlaque, MD; Ehrnström, R; Jakszyn, P; Jansen, EH; Johansson, M; Kaaks, R; Kampman, E; Khaw, KT; Kiemeney, LA; Lagiou, P; Ljungberg, B; Malm, J; Palli, D; Panico, S; Peeters, PH; Riboli, E; Ros, MM; Roswall, N; Sánchez, MJ; Sieri, S; Skeie, G; Tjønneland, A; Trichopoulos, D; Trichopoulou, A; Vrieling, A; Wareham, NJ; Weiderpass, E; Weikert, S | 1 |
| Christensen, J; Dragsted, LO; Olsen, A; Overvad, K; Roswall, N; Tjønneland, A | 1 |
| Chen, HW; Chung, CJ; Hsueh, YM; Huang, YK; Pu, YS; Shiue, HS; Su, CT | 1 |
| Chebil, M; Cherif, M; Elgaaied, AB; Marrakchi, R; Ouerhani, S; Rouissi, K; Sfaxi, M; Slama, MR; Stambouli, N | 1 |
| Cheng, L; Dhawan, D; Fourez, LM; Klein, PJ; Knapp, DW; Koch, M; Leamon, CP; Low, PS; Murphy, L; Naughton, JF; Parker, N; Ramos-Vara, JA; Reddy, JA; Rothenbuhler, R; Stewart, JC; Vlahov, IR | 1 |
| Moriarty, HT; Webster, LR | 1 |
| Bajorin, DF; Boyle, MG; Galsky, MD; Iasonos, A; Mironov, S; Scattergood, J | 1 |
| Atienza, D; Awasthi, S; Berry, W; Delaune, R; Deutsch, M; Dien, PY; Gregory, TF; Hood, K; Hutson, TE; Ilegbodu, D; Kolodziej, MJ; Mull, S; Muscato, JJ; Nicol, S; Raju, RN; Ruxer, RL; Vukelja, S | 1 |
| Goepel, M; Krege, S; Otto, B; Otto, T; Rübben, H | 1 |
1 review(s) available for folic acid and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Fragile sites and bladder cancer.
Topics: Aphidicolin; Carcinoma, Transitional Cell; Cell Transformation, Neoplastic; Chromosome Breakage; Chromosome Fragile Sites; Chromosome Fragility; Chromosomes, Human; Distamycins; Folic Acid; Humans; Urinary Bladder Neoplasms | 2003 |
3 trial(s) available for folic acid and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Drug Administration Schedule; Folic Acid; Glutamates; Guanine; Humans; Infusions, Intravenous; Pelvic Neoplasms; Pemetrexed; Salvage Therapy; Treatment Outcome; Urethral Neoplasms; Urinary Bladder Neoplasms; Urothelium; Vitamin B 12; Vitamin B Complex | 2007 |
Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Female; Folic Acid; Gemcitabine; Glutamates; Guanine; Hematologic Diseases; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Pemetrexed; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium; Vitamin B 12; Vitamin B Complex | 2008 |
[Therapy with mitomycin C, folic acid and 5-fluorouracil in treatment of metastatic, refractory urinary bladder carcinoma--phase II study].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Drug Resistance, Neoplasm; Female; Fluorouracil; Folic Acid; Follow-Up Studies; Humans; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Prospective Studies; Survival Rate; Urinary Bladder Neoplasms | 1997 |
5 other study(ies) available for folic acid and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
One-carbon metabolism biomarkers and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition.
Topics: Aged; Biomarkers, Tumor; Carcinoma, Transitional Cell; Case-Control Studies; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Odds Ratio; Prospective Studies; Risk Assessment; Smoking; Urinary Bladder Neoplasms; Vitamin B 12; Vitamin B 6 | 2019 |
Micronutrient intake and risk of urothelial carcinoma in a prospective Danish cohort.
Topics: Ascorbic Acid; beta Carotene; Carcinoma, Transitional Cell; Denmark; Diet; Diet Records; Female; Folic Acid; Humans; Incidence; Male; Micronutrients; Middle Aged; Nutritional Status; Odds Ratio; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Smoking; Time Factors; Urinary Bladder Neoplasms; Urothelium; Vitamin E | 2009 |
Polymorphisms in one-carbon metabolism pathway genes, urinary arsenic profile, and urothelial carcinoma.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Arsenic; Cacodylic Acid; Carcinoma, Transitional Cell; Case-Control Studies; Cystathionine beta-Synthase; Female; Folic Acid; Genotype; Homocysteine; Humans; Life Style; Male; Metabolic Networks and Pathways; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Risk Factors; Socioeconomic Factors; Taiwan; Urinary Bladder Neoplasms | 2010 |
Smoking and polymorphisms in folate metabolizing genes and their effects on the histological stage and grade for bladder tumors.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Carcinoma, Transitional Cell; DNA Damage; Female; Ferredoxin-NADP Reductase; Folic Acid; Genetic Predisposition to Disease; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Neoplasm Staging; Polymorphism, Genetic; Risk; Risk Factors; Smoking; Thymidylate Synthase; Urinary Bladder Neoplasms | 2011 |
Targeting folate receptors to treat invasive urinary bladder cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Line, Tumor; Disease Models, Animal; Dogs; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Male; Maximum Tolerated Dose; Mice; Mice, Nude; Middle Aged; Pilot Projects; Urinary Bladder Neoplasms; Vinblastine | 2013 |